BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 147246)

  • 1. Serum complement profile in human leprosy and its comparison with immune complex diseases.
    Saha K; Chakraborty AK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):327-37. PubMed ID: 147246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins, complement components and C-reactive protein in sera of leprosy patients and healthy controls.
    Srivastava LM; Agarwal DP; Goedde HW; Rohde R
    Tropenmed Parasitol; 1975 Jun; 26(2):212-8. PubMed ID: 1162738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
    Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary complement deficiencies].
    Fischer E
    Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional significance of complement.
    Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
    Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional state of the complement system in leprosy.
    Gomes GI; Nahn EP; Santos RK; Da Silva WD; Kipnis TL
    Am J Trop Med Hyg; 2008 Apr; 78(4):605-10. PubMed ID: 18385356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulin profile and C3 level in lepromatous leprosy patients.
    Harikrishan S; Balakrishnan S; Bhatia VN
    Lepr India; 1982 Jul; 54(3):454-60. PubMed ID: 7176534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.